FDA Inspection 1325046 — Musculoskeletal Transplant Foundation
The FDA completed an inspection of Musculoskeletal Transplant Foundation on June 25, 2026 in Syracuse, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 25, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Syracuse, NY (United States)